B83.1 Gnathostomiasis

Name of the Condition

• Gnathostomiasis

Summary

Gnathostomiasis is a parasitic infection caused by the larval stages of Gnathostoma nematodes. The larvae migrate through tissues, leading to a range of clinical manifestations, including cutaneous, visceral, or neurological symptoms. The condition is endemic in regions with contaminated freshwater fish or meat, and its presentation varies based on the organs involved and the intensity of infection.

Causes

The infection is caused by the larvae of Gnathostoma species, which are transmitted to humans through the consumption of raw or undercooked freshwater fish, amphibians, reptiles, or other intermediate hosts. Larvae penetrate the intestinal wall and migrate through tissues, causing inflammatory responses and tissue damage. The parasite’s life cycle involves multiple hosts, with humans serving as accidental hosts.

Risk Factors

• Consumption of raw or undercooked freshwater fish, amphibians, or reptiles.
• Residing in or traveling to endemic regions (e.g., Southeast Asia, Latin America).
• Poor food preparation practices, such as inadequate cooking of potentially contaminated meat.
• Occupational exposure to contaminated water or soil in endemic areas.

Symptoms

• Migratory, painful subcutaneous swellings (creeping eruption).
• Gastrointestinal symptoms, including nausea, vomiting, or abdominal pain.
• Neurological manifestations, such as radiculitis, meningitis, or encephalitis.
• Eosinophilia, a common laboratory finding in active infection.

Diagnosis

Diagnosis is based on clinical presentation, exposure history, and laboratory findings. Serological tests (e.g., ELISA) may detect antibodies, though cross-reactivity with other helminths can occur. Imaging (e.g., MRI) may identify larval migration in visceral or neurological cases. Eosinophilia supports the diagnosis, and biopsy of migratory lesions may reveal larvae in rare instances.

Treatment Options

Treatment typically involves anthelmintic therapy, such as albendazole or ivermectin, to target migrating larvae. Corticosteroids may be used to manage severe inflammatory reactions or neurological symptoms. Supportive care, including pain management and monitoring for complications, is essential. Duration of therapy depends on infection severity and response.

Prognosis and Follow-Up

Prognosis is generally favorable with timely treatment, though neurological involvement may lead to residual deficits. Follow-up includes monitoring for symptom resolution, repeat serology if needed, and evaluation for complications. Chronic or severe cases may require extended therapy and multidisciplinary care.

Complications

• Neurological damage, including paralysis or cognitive impairment.
• Visceral organ involvement, such as gastrointestinal perforation or hemorrhage.
• Secondary bacterial infections from skin lesions.
• Persistent eosinophilia or allergic reactions.

Lifestyle & Prevention

• Avoid consuming raw or undercooked freshwater fish, amphibians, or reptiles.
• Ensure proper cooking of meat to kill larvae.
• Practice good food hygiene, including washing hands and surfaces.
• Avoid swimming in or drinking water from potentially contaminated freshwater sources.

When to Seek Professional Help

Seek medical attention if migratory swellings, neurological symptoms, or severe gastrointestinal issues develop, especially after travel to endemic regions. Prompt evaluation is critical for suspected cases to prevent complications.

Tips for Medical Coders

Document the clinical presentation, exposure history, and diagnostic findings to support coding. Ensure the code B83.1 is used for confirmed cases of gnathostomiasis. Include details on treatment, complications, or follow-up when relevant to capture the full clinical context.